NXGB — Nxgen Brands Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $0.54m
- $0.02m
Annual income statement for Nxgen Brands, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 0.04 | 0.015 |
| Cost of Revenue | ||
| Gross Profit | 0.021 | 0.015 |
| Selling / General / Administrative Expenses | ||
| Total Operating Expenses | 0.239 | 0.014 |
| Operating Profit | -0.198 | 0.001 |
| Total Net Non Operating Interest Income / Expense | ||
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -0.247 | -0.049 |
| Net Income After Taxes | -0.247 | -0.049 |
| Net Income Before Extraordinary Items | ||
| Net Income | -0.247 | -0.049 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -0.247 | -0.049 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.004 | -0.001 |